DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Loomba R, Lawitz E, Mantry PS. , et al.
GS-4997, an inhibitor of apoptosis signal-regulating kinase (ASK1), alone or in combination with simtuzumab for the treatment of nonalcoholic steatohepatitis (NASH): a randomized, phase 2 trial.
Hepatology 2016;
64: 1119A-1120A
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.